Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

If you miss the grocery store you grew up with, you're probably not alone. Many popular and once-dominant chains have folded ...

Get insights into top dividend stock picks for 2025 from Barron’s Roundtable, with potential gains ranging from 19.46% to ...

Shares of Westgold Resources (ASX:WGX) tumbled 12.4% following the company's announcement of a significant reduction in its ...

With an Arctic blast coming through the metro, Members of the Beta Alpha Chapter of Omega Psi Phi Fraternity Incorporated spent the day passing out items to those in need.

Neuroscientists have set up computer frameworks that can help model individual brain dynamics.

More on BNY Mellon High Yield Beta ETF Seeking Alpha’s Quant Rating on BNY Mellon High Yield Beta ETF Dividend scorecard for BNY Mellon High Yield Beta ETF ...

Gen X - the forgotten generation - is poised to drive the future. But they need opportunities, experiences and fulfillment.

The Village of Mayfield is working on a deal with developer Premier Mayfield LLC to build a 70,000-square-foot ...

Verus Wealth Management LLC bought a new position in shares of JPMorgan Chase & Co. (NYSE:JPM) in the 4th quarter, according ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

JPMorgan Chase & Co. lifted its holdings in Janus Henderson Small/Mid Cap Growth Alpha ETF (NASDAQ:JSMD – Free Report) by 432.6% during the third quarter, according to its most recent 13F filing with ...